The 2023 Influenza Vaccine Production & Distribution Market Report provides insights into both the previous and current flu seasons, vaccine makeup and effectiveness, and the overall decline in vaccine coverage in the U.S.

Key Insights
  • Doses distributed: 173.4 million doses of the influenza vaccine were distributed during the 2022–2023 flu season.
  • Vaccine effectiveness: A 54% vaccine effectiveness was estimated for the 2022–2023 flu season, the highest since 2013.
  • Adult vaccination rate: 46.9% of U.S. adults received their influenza vaccine in the 2022–2023 flu season.

Members can access a single-license download of the full report via the Member Download button

Member Download